# Post-Approval Study of MelaFind

> **NCT01700114** · — · TERMINATED · sponsor: **MELA Sciences, Inc.** · enrollment: 487 (actual)

## Conditions studied

- Melanoma

## Interventions

- **DEVICE:** MelaFind

## Key facts

- **NCT ID:** NCT01700114
- **Lead sponsor:** MELA Sciences, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** TERMINATED
- **Start date:** 2012-11
- **Primary completion:** 2016-01
- **Final completion:** 2016-01
- **Target enrollment:** 487 (ACTUAL)
- **Why stopped:** FDA withdrew requirement to complete study
- **Last updated:** 2016-03-11


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01700114

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01700114, "Post-Approval Study of MelaFind". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT01700114. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*